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A B S T R A C T
The purpose of this study is to characterize controlled release matrix tablets of captopril and to find out the physicochem-
ical properties that have an effect on the mucoadhesion process. The hydrophilic matrix tablets contain captopril, micro-
crystalline cellulose, barium sulfate, ascorbic acid, ethylcellulose N100, hydroxypropylmethylcellulose K15M, talc, mag-
nesium stearate and colloidal silicon dioxide. The physicochemical properties of the formulations have been characterized
using confocal microscopy, contact angle, and scanning electron microscopy. The potential mucoadhesion capabilities of
the formulations were assessed measuring the surface free energy, the polar and dispersive forces, the spreading coeffi-
cients, the surface roughness, and the network structure of the hydrophilic matrix tablets. The results show that when the
concentration of HPMC K15M increases, the spreading coefficients of polymer over mucus and mucus over polymer are
more positive, thus increasing the contact between the matrix tablets with the mucus layer. The formulation that contains
15% of HPMC K15M is the formulation that presents a greater swelling capacity, a greater increase in surface roughness,
and larger pores within the matrix. This formulation has a higher chain mobility and more free macromolecular chains
able to diffuse in the mucus layer. Therefore, this formulation has the greatest potential mucoadhesion capability.
© 2016 Published by Elsevier Ltd.
1. Introduction
Mucosal drug delivery offers various advantages including the
ability to target local disorders in order to reduce systemic dosage
thereby minimizing side effects, and to promote systemic drug deliv-
ery through various routes of administration [1].
Mucoadhesion has been widely promoted as a way of achieving
site-specific drug delivery through the incorporation of mucoadhesive
hydrophilic polymers within pharmaceutical formulations along with
the active pharmaceutical ingredient (API) [2].
The total phenomenon of mucoadhesion is likely to be a com-
bined result of all the phenomena considered by the different theo-
ries. Some researchers prefer to divide the mucoadhesion process into
sequential phases, each of which is associated with a different mu-
coadhesion mechanism [3,4]. First, the polymer becomes moist and
swells (wetting theory). Then, noncovalent (physical) bonds are cre-
ated within the mucus–polymer interface (electronic and adsorption
theory). Then, the polymer and protein chains interpenetrate (diffusion
theory) and entangle together to form further non-covalent and cova-
lent bonds (electronic and adsorption theory) [5].
Mucoadhesives are characterized by material properties that con-
tribute to good adhesiveness, according to one or more theories of
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mucoadhesion. Such material properties are the ability of mucoadhe-
sives to swell, their ability to form molecular (covalent and non-cova-
lent) bonds with the mucus layer, and their spatial conformation due to
the entanglement of chains. The creation of molecular bonds and the
entanglement of chains lead to changes in the rheological behavior of
the mucoadhesives. The rheological properties of mucoadhesives can
therefore be used as an indication of the extent of molecular bonding
and spatial conformation. The cohesiveness of mucoadhesives con-
tributes indirectly to their adhesive ability, since it concerns the inter-
nal strength of the mucoadhesive [5].
The network structure of a hydrophilic matrix will determine its
properties as a drug delivery device. There are three main parameters
that characterize the hydrophilic matrix network structure:
- The volume fraction in swollen state.
- The molecular weight of the polymer chain between two neighbor-
ing crosslinking points.
- The corresponding mesh size.
The polymer volume fraction in swollen state is a measure of the
amount of fluid absorbed and retained by the hydrogel. The molecular
weight between crosslinks is a measure of the degree of crosslinking
of the polymer. The mesh size provides a measure of the distance be-
tween consecutive junctions or crosslinks. It offers a measure of the
space available between the macromolecular chains for drug diffusion
[6].
http://dx.doi.org/10.1016/j.jddst.2017.03.009
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The aim of this article is to characterize the physicochemical prop-
erties and evaluate the potential mucoadhesion capabilities of hy-
drophilic matrix tablets. Complementary methodologies have been
used (cryo-SEM, contact angle and confocal microscopy) to evaluate
the potential mucoadhesion capabilities of the formulations. A theo-
retical description of the mechanisms involved in mucoadhesion has
been provided to determine which physicochemical properties are in-
volved in the adhesion process. The pharmaceutical development is
described in previous studies [7–10]. Considering that the network
structure of a hydrophilic matrix will determine its properties as a drug
delivery device [6], an exhaustive analysis of the network structure of
the formulations has also been performed.
2. Materials and methods
2.1. Materials
The active substance under study is Captopril (Farmahispania,
Spain).
The excipients used for the formulation of tablets were microcrys-
talline cellulose (Avicel® PH101, FMC Biopolymer (Norway)), bar-
ium sulfate (Panreac, Spain), Ascorbic Acid (Fagron, Spain), ethylcel-
lulose (Ethylcellulose N100®, Aqualon, (USA)), and hydroxypropy-
lmethylcellulose (HPMC K15M Premium®, Colorcon, Inc. (USA)).
Other ingredients used were talc (Fagron, Spain), magnesium stearate
(Fagron, Spain), and colloidal silicon dioxide (Aerosil®, Fagron,
(Spain)).
2.2. Methods
2.2.1. Differential scanning calorimetry (DSC) and
thermogravimetry analysis (TGA)
DSC analyses (DSC 822e, Mettler Toledo, Switzerland) have been
obtained with approximately 5 mg of sample (active ingredient, ex-
cipients and binary mixtures). A nitrogen atmosphere with a flow of
50.0 ml min−1 and a heat flux of 10 °C min−1 in a temperature range
of 30.0–300.0 °C was used. The thermograms were analyzed with the
help of the Mettler Toledo Star System program, recording the peak
positions and quantifying the enthalpy values corresponding to each
endotherm. The possible interactions were deduced from the modifi-
cations of the thermogram parameters of the mixtures with respect to
those seen in the thermograms of pure components.
The thermograms of Captopril, excipients and binary mixtures of
Captopril with each of the excipients in the formulation were analyzed
with a ratio of 1:1 w/w, which corresponds to the theoretical percent-
age of the components in the formulation and with a ratio of 1:2 w/w.
In the case of ethylcellulose and hydroxypropylmethylcellulose, theo-
retical percentages of Formulations 1 and 7 were chosen, respectively.
DSC measurements on pure and hydrated hydroxypropylmethyl-
cellulose were carried out with two different calorimeters, a Q100
calorimeter from TA-Instruments operating between 200 K and
450 K, and a liquid-nitrogen DSC 2920 calorimeter allowing mea-
surements as low as 130 K. In both cases, the heating/cooling rate
was set to 10 K min−1. Thermogravimetry (TGA) scans were also ac
quired on the same samples, while heating the sample under N2 flow
between room temperature (300 K) and 400 K at a rate of 2 K min−1,
by means of a Q50 thermobalance from TA-Instruments.
2.2.2. Experimental design and manufacturing process
The design of two-components (Formulations 1 to 7) was used in
which the variables are the concentration of ethylcellulose N100® and
HPMC K15M Premium® by setting all other components of the for-
mula in a 70% w/w, with a 30% w/w maximum concentration for each
of the variables. The different formulations are shown in Table 1.
The manufacturing process of the formulations was as follows: the
following raw materials were mixed in a container: captopril, ascor-
bic acid, talc, ethylcellulose N100®, HPMC K15M Premium®, barium
sulfate and 70% of the Avicel® PH101. Subsequently the product was
mixed for 2 min, it was sieved in a 0.8 mm sieve, it was transferred
to a suitable container and mixed for 8 min at 20 rpm in the Glatt bi-
conical mixer. This intermediate product is called mixture A. In an-
other container, 30% of the Avicel® PH101, Aerosil® and the mag-
nesium stearate were mixed for 2 min. The product was sieved in a
0.6 mm sieve and was incorporated to mixture A. Finally, the product
was mixed at 20 rpm for 3 min in the biconical Glatt drum.
The blends were compressed in a Bonals® (Cornellà de Llobre-
gat, Spain) continuous eccentric press, provided with 19 × 10 mm
punches. The height varied between 6.15 and 6.45 mm, and the weight
was 1 g. The formulations comply with the uniformity of mass test
(European Pharmacopeia method 2.9.5), since none of the individual
masses deviate from the average mass by more than 5%. The average
hardness values were between 161 and 195 N (see Table 2).
2.2.3. In vitro dissolution studies
Dissolution was measured with a fully calibrated dissolution appa-
ratus, using the paddle method (Apparatus II, Erweka DT80, Switzer-
land). The paddle speed was 50 rpm, temperature 37 °C ± 0.5 °C, and
volume of the medium 900 ml HCl 0.1 N (pH = 1,2), simulating gas-
tric conditions. At predetermined time intervals, 5 ml samples were
withdrawn with replacement. The collected samples were diluted 1:5
with HCl 0.1 N and filtered through the 0.45 μm filters, suitably di-
luted with the release medium, and ab
Table 1
Composition of the different formulations (References [1–7]).
Raw materials Percentage (%)
1 2 3 4 5 6 7
Ethylcellulose N100® 30 25 20 15 10 5 0
HPMC K15M Premium® 0 5 10 15 20 25 30
Captopril 10 10 10 10 10 10 10
Talc 4 4 4 4 4 4 4
Aerosil® 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Magnesium stearate 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Avicel® PH101 25 25 25 25 25 25 25
Ascorbic Acid 20 20 20 20 20 20 20
Barium sulphate 10 10 10 10 10 10 10
Total 100 100 100 100 100 100 100
Table 2
Rupture strength values obtained in the different formulations.
Formulations
1 2 3 4 5 6 7
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sorbance was measured using a UV spectrophotometer (Specord 205
AnalytikJena, Switzerland) at 206 nm and 244 nm to quantify the
Captopril and ascorbic acid, respectively. Experiments were per-
formed on all six media.
A multivariate UV-method was used to determine the concentra-
tion of Captopril and ascorbic acid in the sample aliquots removed
during the dissolution experiment. The calibration model used for pre-
diction was based on UV spectra of 12 calibration samples of known
Captopril and ascorbic acid concentrations. The calibration design em-
ployed ensured that there was no covariance between the two analytes
[10].
The equation of the regression line of captopril relating the con-
centration to the absorbance corresponds to Y = 0.037X – 0.005 at
206 nm. The coefficient of determination is 0.998. The coefficient of
variation of the response factor is 3.9% at 206 nm. With the results
obtained it is shown that the analytical method is linear in the dissolu-
tion test, demonstrating the ability to provide results which are directly
proportional to the concentration of captopril.
The average percentage of captopril in the accuracy test is 98.0%,
and the coefficient of variation in the precision test is 3.4%. The ana-
lytical method developed in order to quantify the captopril in the dis-
solution test complies with the criteria of specificity, linearity, preci-
sion and accuracy in the range between 3 and 25 μg/ml.
The critical quality attribute of major importance is the dissolution
rate. Although the absorption of Captopril is independent of concen-
tration and dose [11], its permeability is concentration-dependent [12].
Furthermore, degradation of Captopril is inversely proportional to the
concentration of dissolved active substance [12], which is of great im-
portance to obtain a knowledge space to allow selecting a formulation
at optimum dissolution rate. The design space was performed based
on the percentages of Captopril dissolved at 180, 360 and 600 min.
The values obtained for each formulation designed were processed
statistically using Statgraphics Centurion XVI software.
2.2.4. Contact angle measurements and surface free energy
determination
The contact angles of water and diiodomethane were determined
against tablets of formulations 1, 4 and 7, using the sessile drop
method. Results were obtained using a Contact Angle System
OCA15plus (Dataphysics, Germany) and were analyzed using SCA20
software (Dataphysics, Germany) in ambient conditions. Using a mi-
cro-syringe, a drop of water (2 μl) and diiodomethane (2 μl) were dis-
pensed onto tablet surfaces with a dosing rate of 1 μl/s. The contact
angle of the drop was recorded at 0 and 1.2 s using the internal cam-
era, and the contact angles observed during this time period were de-
termined by the software incorporated within the system. Three deter-
minations of each formulation were performed with both solvents. The
dispersive and polar surface energy were determined using the angle
of the drop recorded at 0 s.
In the method of Wu [13], solid surface free energy can be as-
sessed by the contact angle measurement of two liquids of known po-
larity and can be assessed by solving one equation with two unknowns
(equation (1)).
where Yl is the liquid surface tension and Ys the solid surface free en-
ergy [14]. The solvents commonly used to determine surface free en-
ergy are water and diiodomethane (see Table 3).
The spreading coefficients of polymer over mucus, mucus over
polymer, and liquid phase over mucus are described in equations
Table 3










(mN/m) Work of cohesion
Water 21.8 50.2 72.0 144.0
Diiodomethane 50.4 0 50.4 100.8
(2)–(4).
where αP and βP are the polar and dispersion forces of the polymer,
αM and βM are the polar and dispersion forces of the mucus, and αL
and βL are the polar and dispersion forces of the gastrointestinal fluid.
The values for the polar and dispersion components of mucus (pig in-
testinal mucosa in isotonic saline: α = [3.52 mN/m]0.5, β = [5.26 mN/
m]0.5), and gastrointestinal fluids (taken as water for which the val-
ues of α = [4.67 mN/m]0.5 and β = [7.14 mN/m]0.5 are considered stan-
dard) [15].
The combined spreading coefficient (Sc) for mucoadhesion is de-
scribed in equation (5):
where (−SL/2)
0.5 is the Griffith fracture energy (YG
0.5).
Bioadhesion can be modeled by use of surface energetics and
spreading coefficients [15]. It is necessary to view the spreading co-
efficient in relation to three phases, namely the drug delivery system,
the mucus layer and the gastrointestinal fluid, where the fluid is dis-
placed from the mucus surface by the polymeric delivery system. Con-
sequently, three spreading coefficients exist, one for the polymer over
mucus (SP), one for mucus over polymer (SM), and the other for the
gastrointestinal liquid over the mucus (SL). The requirement for mu-
coadhesion is that the spreading coefficient for the gastrointestinal liq-
uid over the mucus (in the presence of the polymer) is negative (disfa-
vored). The negative value for SL is a requirement, but not a sufficient
condition, for mucoadhesion. It is also necessary for one of the other
spreading coefficients to be positive (favored) to provide spontaneous
and stable adhesion. This double requirement is a consequence of the
three-phase competitive interaction [16].
Spreading of the mucosal phase is not likely if the adhesive poly-
mer is a hydrogel. Therefore, the mucosa-spreading coefficient (SM)
will always be negative, but can be neglected if SP > 0.
2.2.5. Confocal microscopy
The morphology and surface roughness of the tablets were charac-
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The surface texture was measured with a Confocal Leica 3DCM
microscope with an EPL 20x/0.50 objective, covering an area of
636.61 μm × 477.25 μm. Eight quantitative parameters were used to
characterize the morphology and roughness of the tablet surface of
formulations 1, 4 and 7: arithmetic mean deviation of the surface
(Sa), root-mean-square deviation of the surface (Sq), skewness of the
topography height distribution (Ssk), kurtosis of the topography height
distribution (Sku), 10-point mean of the absolute heights (Sz), height
of highest peak (Sp), depth of deepest valley (Sv), and vertical dis-
tance between the highest peak and deepest valley (St).
Millimeter scale areas of the tablet surfaces were measured using
a confocal microscope (LEICA DCM3D, Leica Microsystems, Ger-
many), which was used to image and measure the roughness of the
tablet surfaces. The measurement Z-range was ±50 μm and the reso-
lution was 500 nm (lateral) and 30 nm (vertical) using image sizes of
0.6 mm × 0.43 mm. Confocal microscopy provides the distribution of
surface peaks and valleys without the need for complex sample prepa-
ration.
2.2.6. Scanning electron microscopy
To observe the amorphous structure of the gel layer, the tablets
were placed in a 400 ml glass beaker with water in a magnetic stir-
rer for 5 s at 300 rpm. Hydrated tablet samples were examined by the
Cryo-SEM method by means of a cryostage (GATAN ALTO-1000,
USA) attached to the scanning electron microscopy (SEM JEOL
JSM-6510, Japan), which can maintain the structure of the hydrated
materials in the most natural state. Hydrated samples were frozen by
plunging them into liquid nitrogen, and then transferred in vacuum
to the cryo-unit system coupled with the SEM. Samples were subli-
mated at −70 °C for 15 s in the SEM chamber in high vacuum condi-
tions. Then, the tablets were relocated in the cryo-unit in order to be
sputtered with gold. The covered samples were finally observed in the
SEM at 10 kV maintaining the temperature at −192 °C. The images
were taken using the tablets of formulations 1, 4 and 7.
2.2.7. Dielectric spectroscopy study of molecular dynamics of
HPMC K15M
To study the interaction of hydroxypropylmethylcellulose (HPMC
K15M) with water and the resulting molecular dynamics, we carried
out a comparative study on three different forms of HPMC: powder,
aqueous solution, and as hydrated thin film. To obtain the aqueous so-
lutions, HPMC K15M was mixed with pure deionized water in a 2%
weight-volume ratio and sonicated for a few minutes to ensure ho-
mogeneity. A rather viscous liquid was obtained. Thin hydrated films
were obtained by slow (ambient temperature) evaporation of the solu-
tion in a glass beaker. All three types of samples were characterized by
DSC and broadband dielectric spectroscopy (BDS). The powder and
the hydrated films were also characterized by TGA to determine their
water content.
For BDS measurements, different capacitor cells were used for
each type of sample. To obtain pellets, the powder was mechanically
pressed between two steel disks, used as capacitor plates. The films
were recovered between the same two disks. As for the aqueous solu-
tions, the samples were inserted at room temperature in liquid form in-
side a home-made stainless steel parallel-plate capacitor, specially de-
signed for liquid samples, with the two cylindrical plates separated by
needle-like silica spacers of 50 μm in diameter. The capacitors were
then loaded into a nitrogen-gas flow cryostat for temperature control.
Dielectric spectra were acquired in the frequency (f) range from 10−1
to 5·106 Hz using a Novocontrol Alpha analyzer. Experiments were
carried out in the temperature range between 500 and 120 K.
Dielectric spectroscopy yields the complex permittivity of a sam-
ple as a function of frequency. In dielectric measurements, an AC
electric field is applied to a parallel-plate capacitor formed by a ho-
mogeneous sample between two metal disks. Using the known surface
area and the thickness of the dielectric sample, the complex permit-
tivity is directly extracted from the complex impedance of the capac-
itor cell, which is measured with an impedance analyzer. This tech-
nique allows probing in the same experiment both the AC conductivity
and the molecular dipolar dynamics. In this study, the dielectric spec-
tra are displayed either as dielectric loss (imaginary permittivity, ε”(f))
or as AC conductivity σ′(f)). The two representations are related by
σ′(f) = 2πf ε0 ε”(f). In the temperature range under study, all samples
displayed one or two losses. The data could be fitted assuming that
each loss was described by a Cole-Cole or Debye function, to which
a background was sometimes added representing the DC conductiv-
ity contribution, following the usual fitting procedure for BDS spectra.
For temperatures below 260 K, each AC conductivity spectrum and
corresponding loss spectrum of these samples was fitted as the sum of
two relaxation processes, modeled one with a Cole-Cole function and
the other a Debye function. The analytic expression of the complex
Cole-Cole function is described in equation (6) [17]:
Here Δε = εs – ε∞ is the dielectric strength, ε∞ and εs are the high-fre-
quency and static low-frequency limits of the real permittivity. The
parameter c, called the Cole–Cole exponent, lies in the range from 0
to 1 and is related to the width of relaxation time distribution; finally,
fmax is the frequency at which the dielectric loss of the given relax-
ation process is highest. The Cole-Cole function is a phenomenologi-
cal modification of the Debye law [18], which is described in equation
(7):
which corresponds to Eq. (6) with c = 1. The characteristic frequen-
cies fmax vary exponentially with temperature and are therefore usually
plotted in the Arrhenius representation (Log(fmax) vs 1/T). The same
holds for the DC-limiting value of conductivity, σdc, defined as the
plateau value in a σ′(f) spectrum.
3. Results and discussion
3.1. Differential scanning calorimetry (DSC) analysis
Table 4 sets out the temperatures and melting enthalpies for each
of the samples tested.
The Captopril DSC curve shows an endotherm between 104 and
113 °C (ΔHmelting = −121 J g
−1), with a melting temperature of
107.3 °C (Tonset) and 109.5 °C (Tpeak).
Captopril presents incompatibility with magnesium stearate [19].
However, this incompatibility depends on the ratio of the components
(see Table 4). One possible explanation is that magnesium stearate in-
creases the pH of the microenvironment of the formulation due to its
basicity, which will interact with Captopril, since it is unstable at ba-
sic pH. However, if an amount of magnesium stearate that does not
modify the pH of the microenvironment of the formulation is added
to the formulation, there is no incompatibility between the two com-
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Table 4









Captopril 107.3 109.5 −121
Drug/excipient 1:1 1:2 1:1 1:2 1:1 1:2
Microcrystalline cellulose
PH101
106.1 104.5 108.8 108.3 −31 −29
Ethylcellulose N100 106.7 105.7 108.5 108.2 −12 −9
Hydroxypropylmethylcellulose
K15M
106.5 105.2 108.9 108.6 −25 −17
Ascorbic acid 105.0 104.4 108.5 108.1 −39 −24
Talc 107.2 106.0 109.4 109.4 −86 −74
Barium Sulfate 106.1 106.2 109.6 109.3 −59 −48
Magnesium stearate 102.2 97.4 107.2 106.7 −100 −84
Colloidal silicon dioxide 105.9 106.2 110.2 109.5 −114 −110
the two components, while with the binary mixture 1:2 w/w, the melt-
ing temperature of Captopril (Tonset) is 97.4 °C, which may suggest a
possible incompatibility between magnesium stearate and Captopril.
The DSC of the mixtures with the other excipients of the formula-
tion obtained can be considered a superposition of the individual pro-
files, highlighting the absence of incompatibilities between Captopril
and excipients.
3.2. Dissolution profiles
Fig. 1 shows the Captopril release profiles from the HPMC matri-
ces where there is a significant change in the release profiles between
5% and 10% w/w of HPMC K15M. Above 10% w/w of HPMC K15M
(the polymer percolation threshold), an infinite cluster of this compo-
nent is formed which is able to control the hydration and release rate
[20]. Above 25% w/w of HPMC K15M, the release rate does not de-
crease, which is normal in formulations of drugs that are highly solu-
ble in water [21].
The burst release effect is more predominant when the percent-
age of ethylcellulose N100 is increased with respect to HPMC K15M.
The dissolution rate of Captopril is inversely proportional to the con-
centration of HPMC K15M. Formulation 4 has the optimum modi
Fig. 1. Dissolution profiles of the different formulations (1–7) in HCl 0.1 N (pH = 1.2)
at 37 °C, and paddle speed at 50 rpm.
fied release profile, since formulations 5, 6 and 7 show a retention of
Captopril in the matrix that does not permit the release of Captopril in
the dissolution test.
3.3. Design space
Fig. 2 shows the models best suited to the data obtained from
the dissolution profiles. At 180 min, the model that best fits is the
square-root X:Y model, while at 360 and 600 min, the model that best
fits is the linear model.
Analysis of variance (ANOVA) was used to study the validity of
the model. Since the p-values in the ANOVA table are below 0.01
(see Table 5), there is a statistically significant relationship between
the percentage of Captopril dissolved at 180, 360 and 600 min with
the formulations for a confidence level of 99%. This indicates that the
three models are valid for relating the variation of responses to the
variation of the factors, which allows describing the design space. At
180 min, there is an interaction between the ethylcellulose and HPMC
K15M in the dissolution rate of Captopril. The interaction between the
components disappears with time and the model becomes linear and is
more linear at 600 min than at 360 min (see Fig. 2).
3.4. Physicochemical characterization of hydrophilic matrix tablets
3.4.1. Wetting properties
The hydration process is essential for the relaxation and interpene-
tration of polymer chains. Controlling the rate and extent of hydration
is required to produce prolonged adhesion. When the concentration of
ethylcellulose N100 increases, the contact angle decreases and, in con-
sequence, the surface free energy and the wettability of the tablets in-
creases (see Tables 6 and 7).
Secondary hydrogen and Van der Waals bonds contribute to the
swelling ability of polymers, which favors the presence of rheologi-
cal synergism and leads to improved mucoadhesion. This spreading
process, controlled by the interfacial energies of the mucus and the
drug delivery system, allows close contact at the mucus–drug delivery
system interface, thus governing the formation of bonds [15].
When the concentration of ethylcellulose N100 increases, the po-
lar and the dispersion forces increase (see Table 7). The values of the
spreading coefficients of polymer over mucus and the spreading co-
efficients of mucus over polymer are negative, which is why these
processes are not spontaneous. However, these processes are more fa-
vored when the concentration of HPMC K15M is increased. Although
the values of the spreading coefficients are negative, the extension of
polymer over mucus will be predominant with respect to the extension
of the mucus over the polymer, since the values of the spreading co-
efficients of polymer over mucus are less negative than the values of
spreading coefficients of mucus over polymer. The extension process
of the mucus over polymer cannot be neglected because the values of
the spreading coefficients of the polymer over mucus are not positive
(see Fig. 3). The combined spreading coefficient has not been calcu-
lated because the values of the spreading coefficients of polymer over
mucus are negative. For this reason, all the spreading coefficients (SP,
SM and SL) have to be taken into account to predict the bioadhesion of
the formulations. All values of spreading coefficients of liquid phase
over mucus are negative, indicating that this process is not sponta-
neous. However, when the concentration of HPMC K15M increases,
the liquid phase tends to spread less in the mucus layer (see Fig. 3),
and the spreading coefficients of polymer over mucus and mucus over
polymer are more positive. Therefore, the contact between the matrix
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Fig. 2. Equations of the models at 180, 360 and 600 min. The X axis corresponds to formulations, while the Y axis corresponds to % Captopril dissolved.
Rough surfaces also provide an increased surface area available
for interaction along with enhanced viscoelastic and plastic dissipation
of energy during joint failure, which are thought to be more impor-
tant in the adhesion process than a mechanical effect. Table 8 shows
the parameters of surface texture analysis of formulations 1, 4 and
7, after wetting. Formulation 4 presents the highest value of Sq (root
mean square of height). The Sdar/Spar ratio is shown in Table 8,
where Sdar is the total developed area of a rough surface, and Spar
is the projected area: 303,822 μm2 = 636.61 × 477.25 μm2. This ratio
represents the value of developed area per unit of projected area and
is connected with the volume of the surface roughness (volume of
peaks and valleys). The developed area ranges from around 112 times
the projected area for formulation 1 to 1508 times for formulation
4. After water uptake, all parameters show a greater swelling surface
in formulation 4 than in the other two formulations. Formulation 4
presents a greater swelling capacity and a greater increase in surface
roughness (see Table 8), therefore there is more available surface to
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Table 5











X:Y square root model for % response Captopril dissolved at 180 min.
Model 3391.81 1 3391.81 43.68 0.0012∗
Residuals 388.222 5 77.6445
Total 3780.03 6
Linear model for % response Captopril dissolved at 360 min.
Model 1909.05 1 1909.05 36.90 0.0017∗
Residuals 258.677 5 51.7354
Total 2167.73 6
Linear model for % response Captopril dissolved at 600 min.
Model 1358.04 1 1358.04 58.25 0.0006∗
Residuals 116.579 5 23.3157
Total 1474.61 6
∗p-value <0.01 indicates significance level.
Table 6





contact angle (θR) Contact angle Hysteresis
Formulation 1 34°± 2 0°± 0 34°
Formulation 4 38°± 5 0°± 0 38°








Formulation 1 31°± 5 0°± 0 31°
Formulation 4 31°± 3 0°± 0 31°
Formulation 7 36°± 1 0°± 0 36°
Table 7










Formulation 1 29.0 43.9 72.9
Formulation 4 27.1 44.1 71.2
Formulation 7 27.3 41.7 69.0
3.4.2. Network structure of the hydrophilic matrix tablets
Although many factors are involved in such processes, the funda-
mental properties that significantly influence this inter-movement are
cross-linking density, molecular weight, chain mobility/flexibility and
expansion capacity of both networks [2].
High cross-linking restricts mucoadhesive ability by decreasing the
amount of free macromolecular chains able to diffuse in the mucus
layer [5]. The degree of cross-linking within a polymer system sig-
nificantly influences chain mobility and resistance to dissolution. As
cross-link density increases, chain mobility decreases and hence the
effective chain length which can penetrate into the mucus layer de-
creases, reducing mucoadhesive strength [2].
When the concentration of HPMC K15M increases, the cross-link-
ing density increases (see Fig. 4). The porosity of formulation 1 is pro-
duced by the dissolution of the components as it has no HPMC K15M
in the formulation, which is why tablet integrity decreases due to not
having crosslinks that enable tablet strength in the aqueous medium.
The porosity of formulations 4 and 7 is generated by the crosslinking
between the HPMC K15M chains. When the concentration of HPMC
K15M increases, pore size decreases (see Fig. 4). The integrity of
the tablet decreases by increasing the percentage of the ethylcellulose
N100 in the formulation [8].
With the results obtained and taking into account that as the con-
centration of HPMC K15M increases, the degree of crosslinking in-
creases, formulation 4 has a greater mucoadhesive ability compared to
formulation 7, since the availability of HPMC K15M chains for diffu-
sion in the mucus layer is greater. Furthermore, due to the larger pore
size, mucin glycoproteins can penetrate the matrix tablets more easily,
favoring the physicochemical interactions of the components of mu-
cus with the components of the hydrophilic matrix, thus increasing the
mucoadhesion of the formulation.
3.5. Thermophysical characterization and dielectric spectroscopy of
HPMC K15M
Chain flexibility is critical for interpenetration and entanglement
with the mucus. Increased chain mobility leads to increased inter-dif-
fusion and interpenetration of the polymer within the mucus network
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Table 8
Surface texture parameters of formulations 1, 4 and 7, after wetting.
Parameter Formulation 1 Formulation 4 Formulation 7
Amplitude Parameters
Sa 14.798 46.360 24.821
Sq 23.464 68.668 38.821
Sz 240.265 548.164 307.768
Sp 112.393 266.356 169.584
Sv 141.941 303.511 142.300
St 254.335 569.867 311.884
Ssk −1.496 −0.748 0.504
Sku 8.653 5.477 5.953
Other parameters 3D
Sdar 34,282,010 458,196,407 171,963,409
Spar 303,822 303,822 303,822
Sdar/Spar 112.8 1508.1 566.0
[2]. In view of this, we have employed broadband dielectric spec-
troscopy (BDS) to characterize the chain flexibility/mobility of pure
and hydrated hydroxypropylmethylcellulose (HPMC K15M), the ex-
cipient that has the adhesive properties. We have only considered
HPMC K15M and an aqueous mixture thereof due to the intrinsic
difficulty of considering ternary mixtures (hydroxypropylmethylcel-
lulose, ethylcellulose and water), and because HPMC K15M in con-
tact with water forms the gel layer responsible forthe adhesiveness of
the tablet. The totally different aqueous behavior of ethylcellulose and
HPMC K15M can be observed in the right-hand panels of Fig. 4: the
samples containing HPMC K15M display a formation of structures
with smooth boundaries and interconnected by polymer filaments (for-
mulations 4 and 7); such structures are completely absent from formu-
lation 1, which exhibits pointed, rough surfaces with no signs of fila-
mentation.
The glass transition temperature of the HPMC K15M powder (see
inset to Fig. 5(a)) was measured by DSC as being Tg ≈ 445 K, in
agreement with previous studies on hydroxypropylmethylcellulose
[22,23]. The TGA thermogram of the polymer (Fig. 5(a)) shows a
mass loss between 320 and 380 K, peaking at 350 K, the typical des-
orption temperature of physisorbed water. The glass transition temper-
ature marks the freezing of the cooperative segmental dynamics of the
polymer chains. Such dynamics, usually called primary or α relaxation
dynamics, are readily detected by BDS in dipolar samples, including
many polymers [18] and hydrated samples [24]. The dielectric spectra
of the HPMC K15M powder did not show any loss feature above Tg,
which indicates that the dipole moment per unit volume of the poly-
mer is too low to be detected by the technique. However, a relatively
weak loss feature is observed at and below room temperature. This di-
electric feature is related to the presence of physisorbed water, and in
fact it disappears upon heating to 400 K.
Very similar behavior was observed for thin HPMC K15M films
obtained by slow evaporation of the solution. As can be seen in Fig.
5(b), the relative water content is higher in the films than in the pow-
der. The dielectric loss spectra of a particular thin film sample are
shown in Fig. 6(a). A main dielectric loss is visible, accompanied by a
weaker feature at higher temperature. Both features shift to higher fre-
quency with increasing temperature, as expected. The low frequency
background visible in the spectra acquired at a temperature of 253 K
or higher is due to electrical conduction in the film. The dielectric
strength of room temperature relaxation in the film is higher than that
in the powder, as may be expected due to the lower water content in
the latter. Also, in this case relaxation is lost upon heating to 400 K,
i.e., when all water is desorbed.
The loss spectra of the 2% aqueous solution, shown in Fig. 6(b),
are considerably different from those of the films and powder. Above
0 °C, the spectral lineshape appears dominated by ionic conduction
phenomena in the solution, which usually hinders the observation of
dipolar relaxations [25]. DSC characterization of the same sample
showed that the solution underwent at least partial crystallization just
below the freezing temperature of pure water (the melting across this
temperature is shown in the inset to Fig. 6). This phenomenon can be
seen by the dramatic change in lineshape between the temperatures of
267 and 263 K in Fig. 6(b). Below this temperature, the spectra exhibit
two clearly resolved loss features.
To determine the origin of the two loss features observed in the
partially crystallized solution, we analyzed the AC conductivity spec-
tra (Log(σ′) vs Log(f)) of the same 2% sample, plotted in Fig. 7(a).
As can be seen in the Figure, the conductivity spectra above 265 K
are indeed dominated by the DC conductivity of the sample, shown
as a straight plateau at high frequency. In these spectra the bending
at lower frequencies corresponds to a space-charge effect, i.e., to the
accumulation of charges (ions) at the sample's heterogeneities (bound-
aries between amorphous and crystalline domains), which results in
lower conductivity. The partial crystallization at approximately 265 K
is accompanied by a reduction of the DC conductivity by two orders
of magnitude. The spectra below 265 K are more structured than those
above: the high-frequency region displays a plateau corresponding to
the DC conductivity, but the spectral region of the electrode polariza-
tion effect is seen to contain an additional feature. The two bump-like
features that can be observed in the AC conductivity spectra below
265 K correspond to the two features visible in the permittivity (loss)
representation in Fig. 6(b).
The spectra of Figs. 6(b) and 7(a) were fitted as the sum of two
separate components plus a conductivity background. The higher-fre-
quency loss, visible as a shoulder to the main peak in Fig. 7(a), can
be unambiguously assigned to the electrode-polarization effect, while
the lower-frequency loss (main peak) is ascribed to an intrinsic dipo-
lar loss of the sample. Indeed, the decrease in AC conductivity ex-
actly matches the maximum of the higher frequency loss, and, in turn,
such loss could be modeled with a Debye function, as it is typical
for space-charge losses [18]. Moreover, in Fig. 7(b) we compare the
temperature dependence of the characteristic frequency fmax for both
losses with that of the DC conductivity σdc (plateau value of the σ′(f)
spectra at high frequency). The Arrhenius plot of σdc, at least be-
low 220 K, displays the characteristic negative curvature, typical of
disordered ionic conductors [26,27]. It is observed that, at least at
low temperature (below approximately 200 K, corresponding to 1000/
T = 5 K−1), where the dipolar relaxation and the conductivity relax-
ation are clearly separated, the slopes of the Arrhenius plots (effec-
tive activation energies) of both σdc and of fmax for the faster relax-
ation are virtually identical, signaling a common origin of both and
thus corroborating the assignment of this feature as a conductivity-re-
lated (space-charge) loss [28,29].
The lower-frequency loss is a true dipolar loss, and it had to be
modeled with a Cole-Cole function (Eq. (6)). The observation of clear
dipolar relaxation indicates that crystallization near 0 °C is only par-
tial, that is, it leads to the formation of crystalline (ice) domains amidst
an amorphous polymeric matrix. Conversely, regions where the con-
centration of water is lower do not crystallize. These amorphous re-
gions are responsible for the dipolar loss observed. Since the poly-
mer does not have a sufficiently large dipole moment for detection
by BDS, such dipolar feature involves the motion of water molecules.
However, since the solution is initially homogeneous prior to crys-
tallization, the amorphous domains that do not crystallize must re-
tain a significant degree of mixing of polymer chains and water mol-
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Fig. 4. Morphology of the tablets of formulations 1, 4 and 7 moistened with water. The images were examined by Scanning Electron Microscopy (SEM).
spond to a collective relaxation motion of water molecules linked to
cellulose chains.
To confirm that the dipolar relaxation of Fig. 6(b) at least partially
also reflects the mobility of the polymer chains, Fig. 8 shows the Ar-
rhenius plot of the characteristic relaxation times of the main (dipolar)
loss in all three samples studied (quasi-pure polymer, hydrated film,
partially amorphous polymer-water mixture).
It may be observed that, while the frequencies of the water-in-
duced loss in the powder and thin film samples are almost overlap-
ping and have an identical slope (effective activation energy), de-
pending on the temperature the characteristic frequency of the dipo-
lar relaxation in the aqueous mixture can be one order of magnitude
smaller or larger than the latter two (as also discernible directly from
Fig. 6), and moreover it displays a totally different activation energy.
This is a clear indication that while the main losses in the film and in
the powder are due to physisorbed water molecules whose reorienta
tional motions are basically independent of the polymer, in the aque-
ous mixture the water-induced relaxations are strongly influenced by
the presence of the polymer chains. Indeed, this observation confirms
the idea that the relaxation in the partially amorphous mixtures is a
truly collective (water + polymer) relaxation.
The temperature behavior of the dipolar loss of the aqueous mix-
ture could be modeled using a Vogel-Fulcher-Tammann (VFT) depen-
dence, which is described in equation (8) [18]:
Here the prefactor f0, the strength parameter s and the so-called Vo-
gel-Fulcher temperature TVF are phenomenological parameters. The
fit is shown along with the experimental data in Fig. 8(a). Using
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Fig. 5. Thermogravimetry curve (thick line) and derivative thermogram (thin line) of
the HPMC K15M powder (a) and of a hydrated HPMC K15M film (b). Measurements
are carried out by heating at 2 K per minute. Both samples exhibit a mass loss peak-
ing at 350 K due to desorption of physisorbed water. Inset to (a): Differential scanning
calorimetry thermogram of the HPMC K15M powder, measured by heating at a rate of
10 K per minute. A glass transition is observed at approximately 445 K.
temperature for this molecular dynamic process, defined as the tem-
perature at which the characteristic motion time reaches 100 s, or
equivalently fmax = 10
−2/2π Hz ≈ 1.59 × 10−3 Hz. The extrapolated
freezing temperature is roughly 140 K. This temperature is found to
be close to (though slighly lower than) the temperature of the anom-
aly observed with low-temperature DSC on the same sample, as re-
ported in the inset to Fig. 8 (roughly 160 K; the anomaly is more visi-
ble upon cooling than heating). The fact that the freezing temperature
of the dipolar process coincides with a calorimetry anomaly confirms
that such process has a molecular dynamic origin, and corresponds in
fact to dipolar dynamics in the amorphous (non-crystallized) part of
the sample.
To summarize, we assign the slower relaxation feature to the cou-
pled molecular motions of water and the hydrated cellulose chains.
The freezing temperature obtained, 165 K, can be taken to be the ap-
proximate freezing temperature of local motions in the polymer-water
gel. The high mobility of the HPMC K15M chains is an effect of the
swelling, which effectively disentangles the chains, and of the interac-
tion with the liquid-like aqueous matrix.
4. Conclusions
It has been demonstrated that the combination of equations based
on the wettability, the surface free energy, the swelling of the tablets,
and the diffusion of the HPMC K15M chains, along with the micro-
scopic characterization of the hydrophilic matrix, allows us to obtain
Fig. 6. (a). Isothermal dielectric loss spectra (imaginary permittivity, ε) of the same
(hydrated) HPMC K15M film as in Fig. 6(b). Spectra are shown only at selected temper-
atures (every 10 K) for greater clarity. (b) Analogous spectra of the 2% solution, every
8 K. Inset: Differential scanning calorimetry thermogram acquired upon heating at 10 K
per minute the 2% solution, showing (partial) melting above 273 K (0° C).
scientific knowledge that enables characterizing the variables that
have an impact in the mucoadhesion process. Considering the tablet
surface free energy and the spreading coefficients, when the concen-
tration of HPMC K15M increases, adhesion to the mucus layer will
be increased, as the contact between the tablet surface and the mucosa
is favored. Formulation 4 is the one that presents greater swelling, a
greater increase in surface roughness, and larger pores within the ma-
trix. These results show that formulation 4 has a higher chain mo-
bility, more free macromolecular chains able to diffuse in the mucus
layer, and more contact between the tablet surface and the mucosa,
and therefore this formulation has the greatest potential mucoadhesion
capability. The dielectric spectroscopy study reveals that when mixed
with water, HPMC K15M exhibits joint molecular relaxation motions
with water molecules. Such motions are observed below the freez-
ing point of water but are obviously also present at room temperature,
i.e., far below the glass transition temperature of pure HPMC K15M
(172 °C). We assign the relaxation motions to fully hydrated HPMC
K15M chains, which are responsible for the adhesive properties of the
polymer.
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Fig. 7. (a). Alternating-current (AC) conductivity spectra (σ′) of the partially crystal-
lized 2% mass/volume sample, every 4 K. 7(b) Comparison between the characteristic
times and the direct-current (DC) conductivity (σDC) (both vertical scales span the same
number of decades).
Fig. 8. Arrhenius plot of the characteristic frequencies fmax of the most prominent loss
in all three forms of HPMC K15M studied (powder, film, aqueous mixture). Inset:
low-temperature differential scanning calorimetry thermogram of the 2% mass/volume
sample.
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